Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Quintiles and Allscripts have partnered to jointly develop software solutions for clinical and post-approval research.
Subscribe to our email newsletter
The collaboration focuses on late-phase research, recruiting for and monitoring of clinical trials, and post-market surveillance.
The partnership aims at developing products that overcome obstructions in clinical research, outcomes, education and proof of new compound safety, effectiveness and value.
Quintiles R&D Innovation, IT, vice president Gavin Nichols said, "We believe biopharma, patients, providers and payers all will benefit from the technology solutions that grow from this undertaking."
The new solution will enable customers to leverage de-identified longitudinal data, which could enable companies to improve the efficiency of processes involved in the development and evaluation of new drugs, from many sources in a HIPAA-compliant manner.